Abstract
Cancer patients frequently develop hematological problems that require direct management. Understanding their pathophysiology provides one with important clinical insight that directs appropriate therapeutic interventions.
Similar content being viewed by others
References
Andersohn F, Konzen C, Garbe E. Systemic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657–65.
Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7.
Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017;377:1177–87.
Escobar MA. Bleeding in the patient with a malignancy: is it an acquired factor VIII inhibitor? Cancer. 2012;118:312–20. https://doi.org/10.1002/cncr.26304.
Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2012;11:223–33.
Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology. 2007;23:105–19.
Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348–60.
Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the US population: age, sex, smoking status and ethnic differences. Ann Intern Med. 2007;146:486–92.
Hsieh MM, Tisdale JF, Rodgers GP. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol. 2010;28:1633–7.
Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370:847–59.
Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. https://doi.org/10.1016/j.amjmed.2003.12.008.
Laskin B, Goebel J, Davies S, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy. Blood. 2011;118:1452–62. https://doi.org/10.1182/blood-2011-02-321315.
Lebovic D. (2018) Anemia in Malignancy. In: Provenzano R., Lerma E., Szczech L. (eds) Management of Anemia. Springer, New York, NY.
Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845–54.
Leyland-Jones B, Bondarenko I, Nemsadze G, et al. A randomized, open-label, multicenter, phase III study of Epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy. J Clin Oncol. 2016;34:1197–207. https://doi.org/10.1200/JCO.2015.63.5649.
Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016;12:522–30.
Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1:2295–301.
Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009;23:105–11.
Rodgers GM et al. Cancer- and chemotherapy-induced anemia. NCCN Clinical Practice Guidelines in Oncology Version 2.2018 – 11/21/2017. 2017.
Sanford RA, Kroll MH. Cancer-associated thrombosis. In: Kantarjian HM, Wolff RA, editors. The MD Anderson manual of medical oncology. 3rd ed. New York: McGraw-Hill; 2016.
Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36:283–99.
Smith TJ, Bohlke K, Armitage JO. Recommendations for the use of white blood cell growth factors: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract. 2015;11:511–3.
Tas F, Eralp Y, Basaran M, et al. Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol. 2002;25:371–9.
Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723–9.
Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124(8):1251–8. https://doi.org/10.1182/blood-2014-02-482612.
Mantha S et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017;129(13):1763–1767. https://doi.org/10.1182/blood-2016-10-747170.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Casteel, K.N., Kroll, M.H. (2019). Benign Hematological Diseases in Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_101-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-74698-2_101-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74698-2
Online ISBN: 978-3-319-74698-2
eBook Packages: Springer Reference MedicineReference Module Medicine